Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)

NCT01019928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Sensitivity in Esophagus

Interventions

DRUG: AZD1386
DRUG: Placebo to AZD1386

Sponsor

AstraZeneca